Bogle Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
EAM
CTA
EA
EMFAT
Bogle Investment Management's NEO Position: Q1 2019 in Review
Bogle Investment Management sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 75,409 shares — an estimated $951K sold.
Bogle Investment Management first reported a position in NEO in Q3 2014 and held it in 3 quarters. The position peaked at $1.07M in Q3 2014. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.
- Bogle Investment Management reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
- Bogle Investment Management sold 75,409 NeoGenomics shares in Q1 2019, an estimated $951K.
- Bogle Investment Management first reported a position in NeoGenomics in Q3 2014 and held it in 3 quarters.
- Bogle Investment Management's NeoGenomics position peaked at $1.07M in Q3 2014.
- 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.
Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.